MH

Margalit Haber

Transformation, Strategy, & Operations, Amgen

Raleigh-Durham-Chapel Hill Area

Invests in

  • Min Investment:

    $5,000,000.00
  • Max Investment:

    $10,000,000.00
  • Target Investment:

    $7,500,000.00

Work Experience

2022

  • R&D Transformation, Strategy, and Operations | Precision Medicine

    2024

  • Data and Digital Business Development | AI Strategy and Execution

    2022 - 2024

2019 - 2022

  • VC, Associate

    2019 - 2022

    Osage University Partners (“OUP”) is a venture capital fund that invests in spinouts from a network of over 100 affiliated universities and research institutions. OUP has over $600 million in assets under management and has invested in over 115 university spinouts across both tech and life sciences. A list of our portfolio can be found on our website: https://oup.vc/portfolio/ • Assessed a broad range of life science technologies within the areas of therapeutics, diagnostics, research tools and medical devices from the US, UK, and Israel. • Grew my network in order to learn more about the many exciting opportunities and technologies spinning out of the university ecosystem. • Personally perform deep scientific diligence and literature reviews, clinical trial design/feasibility assessments, team reference calls, key opinion leader calls, financing strategy assessments, competitive landscape reviews, and returns analysis. • Prepared and presented investment memos in order to get key stakeholders buy in on deals of interest.

2019 - 2019

  • Product Manager

    2019 - 2019

    Led customer discovery and marketing strategy for several antibody characterization service offerings; Operated in a cross-functional role assisting the sales, marketing, and service teams; Evaluated and updated current business plan to improve the service capabilities and increase sales; Assisted in creation of marketing materials for the antibody characterization services and therapeutic antibody discovery platform; Increased customer discovery activities at the company by generating brief questionnaires and conducting interviews leading to more accurate competitor analyses.

  • Life Science Venture Capital Fellow

    2018 - 2019

    Aided in due diligence on two life science start-ups which included extensive literature reviews, clinical trial design/feasibility assessments, creating questions for and conducting key opinion leader calls, and competitive landscape reviews; Shadowed investment team members.

  • Postdoctoral Research Scientist

    2016 - 2019

    Worked in the lab of Dr. Ramon Diaz-Arrastia studying potential therapeutics and prognostic biomarkers for traumatic brain injury; Led 5 clinical research projects in traumatic brain injury biomarker discovery resulting in 2 first author publications and 5 oral presentations at both domestic and international conferences; Forged and oversaw interdisciplinary collaborations across 3 STEM labs from the departments of engineering, imaging, and cardiology resulting in 3 publications; Acted as the neuroimaging liaison between UPenn and the multi-center TRACK-TBI study to successfully implement novel, advanced imaging sequences at UPenn.

  • Co-Founder

    2018 - 2018

    Cofounded two life science start-ups, a cervical cancer diagnostic and a pH-sensitive nanoparticle therapeutic; Consulted with the FDA, pharmacists, and clinicians to determine the most efficient regulatory route for clinical trials and commercialization; Conducted market research by organizing and distributing a brief survey to clinicians determining potential market penetration of our diagnostic. • Featured in Technical.ly Philly: https://technical.ly/startups/philly-biotech-startups-freedom-from-cancer-startups-challenge/

  • Postdoctoral Research Scientist

    2015 - 2016

    Worked at the Center for Neuroscience and Regenerative Medicine (CNRM) with Drs. Carlo Pierpaoli and Ramon Diaz-Arrastia studying neuroimaging biomarkers for traumatic brain injury.

  • Graduate Research Assistant/PhD Candidate

    2010 - 2015

    Worked in the lab of Dr. Peter J. Bergold investigating the neuroregenerative mechanisms associated with a therapeutic drug combination in a rodent model of traumatic brain injury; Led 3 preclinical research projects in traumatic brain injury rodent models to assess the molecular and cellular mechanisms underlying a potential therapeutic treatment for mild injury resulting in 2 first author publications; Selected as the winner of the Robert F. Furchgott Award for Excellence in Research in 2015 from my graduate cohort, given to the most outstanding PhD thesis from the graduating cohort; Managed daily lab operations; including ordering reagents and rodents, cleaning benches, maintaining internal data sets, and communicating with the facilities manager to fix utilities; Trained undergraduate students, medical students, PhD Candidates, and Postdoctoral fellows in various animal and wet bench-based techniques.

  • Founder and Curator

    2013 - 2015

    Founded and organized a rotating art gallery in the Graduate Student Lounge at SUNY Downstate that featured artwork created by the institution’s graduate students; Identified artistic students and approached them for submissions; Secured funding for materials to display the art and refreshments for opening show; Organized an opening show every 3 months.

  • Co-Founder and President

    2011 - 2014

    Co-founded and led a service contract business printing large format posters for PhDposters.com; Established the first New York City location for a PhDposters branch; Identified potential leads and created targeted marketing materials including laboratory fridge magnets for students and e-mails to administrators to advertise the business to institutions throughout NYC; Served multiple universities throughout NYC including Columbia, NYU, Mount Sinai, CUNY, and SUNY; Worked daily on all aspects of the business from preparing tax forms to fixing mechanical issues on necessary equipment; Successfully sold and transferred business to a new owner.